Clinical Trials in Torette, Ancona

Find clinical trials in Torette, Ancona. Discover local research opportunities and treatment options in your area.

5 Active Trials Found in Torette

Showing 5 trials on this page

Page 1 of 1

Program to Assess Adverse Events and Change in Disease Activity of Oral Upadacitinib in Adult Participants With Moderate to Severe Systemic Lupus Erythematosus

NCT ID: NCT05843643

This clinical trial is studying the safety and effectiveness of a medication called upadacitinib for adults with moderate to severe systemic lupus erythematosus (SLE), a disease that causes inflamm...

Recruiting

Phase: PHASE3 Conditions: Systemic Lupus Erythematosus

Efficacy and Safety of Subcutaneous Dupilumab for the Treatment of Adult Participants With Chronic Pruritus of Unknown Origin (CPUO) (LIBERTY-CPUO-CHIC)

NCT ID: NCT05263206

This clinical trial, called LIBERTY-CPUO-CHIC, is studying a treatment called dupilumab for adults who experience severe itching, known as chronic pruritus of unknown origin (CPUO). The main goal i...

Recruiting

Phase: PHASE3 Conditions: Pruritus

FrexalimAB in Preservation of Endogenous insULIN Secretion Compared to Placebo in adUlts and Adolescents on Top of inSulin Therapy (FABULINUS)

NCT ID: NCT06111586

The FABULINUS trial is studying a new treatment called frexalimab for people with Type 1 Diabetes Mellitus (T1D) who are already using insulin. The goal of the trial is to see if frexalimab can hel...

Recruiting

Phase: PHASE2 Conditions: Type 1 Diabetes Mellitus

A Study to Test an Oral Medicine, Belumosudil, in Combination With Corticosteroids in Participants at Least 12 Years of Age With Newly Diagnosed Chronic Graft Versus Host Disease.

NCT ID: NCT06143891

This clinical trial is studying a new oral medicine called Belumosudil, used together with corticosteroids to treat newly diagnosed chronic graft versus host disease (cGVHD) in patients aged 12 and...

Recruiting

Phase: PHASE3 Conditions: Chronic Graft Versus Host Disease

A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma

NCT ID: NCT06630806

This clinical trial is studying a new treatment called SAR446523 for adults with relapsed or refractory multiple myeloma, a type of blood cancer. The study is divided into two parts. In the first p...

Recruiting

Phase: PHASE1 Conditions: Plasma Cell Myeloma Refractory

Search All Trials Browse All Locations